ArticleRSC advances2021
Gold nanoparticles grafted with chemically incompatible ligands.
Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Active Plasmonics with Responsive, Binary Assemblies of Gold Nanorods and Nanospheres.Nanomaterials (Basel, Switzerland) · 2021Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Janus-type structures were obtained from gold nanoparticles grafted with two types of chemically incompatible mesogenic ligands with a strong tendency for nano-segregation. A lamellar arrangement, in which metallic nanoparticle-rich sublayers are separated by organic ligand-rich sublayers of various composition, was formed due to the ligand segregation process. The layers could be easily aligned by mechanical shearing; for most materials the layer normal was parallel to the shearing direction but perpendicular to the shearing gradient, such transverse mode is only rarely observed for lamellar materials. Reversible changes of layer thickness under UV light were observed due to the presence of an azo-moiety in the organic ligand molecules.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.